Dysregulated m6A via compensatory arginine methylation primes premalignancy in metabolic dysfunction–associated steatotic liver disease
Hepatocellular carcinoma (HCC) originates from premalignant disease-associated hepatocytes (daHeps) that emerge during the progression of metabolic dysfunction–associated steatotic liver disease (MASLD) to metabolic dysfunction–associated steatohepatitis (MASH). As daHeps are compensatorily primed by metabolic stress,...